Five-year risk of CIN 3+ to guide the management of women aged 21 to 24 years

HA Katki, M Schiffman, PE Castle… - Journal of lower …, 2013 - journals.lww.com
Objective Current US national guidelines recommend beginning screening at age 21 using
Pap tests only, with cotesting starting at age 30. To inform the management of Pap test …
被引用次数：50 相关文章

Five-year risk of CIN 3+ to guide the management of women aged 21 to 24 years

HA Katki, M Schiffman, PE Castle… - Journal of lower …, 2013 - einstein.elsevierpure.com
OBJECTIVE: Current US national guidelines recommend beginning screening at age 21
using Pap tests only, with cotesting starting at age 30. To inform the management of Pap test …

Five-year risk of CIN 3+ to guide the management of women aged 21 to 24 years

HA Katki, M Schiffman, PE Castle… - Journal of lower …, 2013 - pubmed.ncbi.nlm.nih.gov
Objective Current US national guidelines recommend beginning screening at age 21 using
Pap tests only, with cotesting starting at age 30. To inform the management of Pap test …

Five-year risk of CIN 3+ to guide the management of women aged 21 to 24 years.

HA Katki, M Schiffman, PE Castle… - Journal of Lower …, 2013 - europepmc.org
Objective Current US national guidelines recommend beginning screening at age 21 using
Pap tests only, with cotesting starting at age 30. To inform the management of Pap test …
[HTML] nih.gov

[HTML][HTML] Estimating 5-year risk of CIN3+ to guide the management of women aged 21–24

HA Katki, M Schiffman, PE Castle… - Journal of lower …, 2013 - ncbi.nlm.nih.gov
Objective Current US national guidelines recommend beginning screening at age 21 using
Pap tests only, with cotesting starting at age 30. To inform the management of Pap test …

Five-year risk of CIN 3+ to guide the management of women aged 21 to 24 years.

HA Katki, M Schiffman, PE Castle… - Journal of Lower …, 2013 - europepmc.org
Objective Current US national guidelines recommend beginning screening at age 21 using
Pap tests only, with cotesting starting at age 30. To inform the management of Pap test …